Connection

KEVIN DUONG to Humans

This is a "connection" page, showing publications KEVIN DUONG has written about Humans.
Connection Strength

0.054
  1. Incidence and risk factors of new clinical disorders in patients with COVID-19 hyperinflammatory syndrome. Sci Rep. 2025 Jun 06; 15(1):19892.
    View in: PubMed
    Score: 0.024
  2. New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx. Sci Rep. 2024 12 30; 14(1):31850.
    View in: PubMed
    Score: 0.006
  3. Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections. Proc Natl Acad Sci U S A. 2022 05 31; 119(22):e2122506119.
    View in: PubMed
    Score: 0.005
  4. Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency. Blood Adv. 2021 12 14; 5(23):4864-4876.
    View in: PubMed
    Score: 0.005
  5. The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53. Neoplasia. 2021 06; 23(6):624-633.
    View in: PubMed
    Score: 0.005
  6. Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production. Sci Transl Med. 2021 02 03; 13(579).
    View in: PubMed
    Score: 0.004
  7. Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling. Oncogene. 2021 03; 40(9):1690-1705.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.